Professor Kawthar Bouchemal is a distinguished leader in pharmaceutical nanotechnology whose pioneering research bridges polymer science with advanced drug delivery systems. She currently holds the position of Full Professor in Polymer Physical Chemistry and Formulation at Chimie ParisTech – PSL University, where she has established a world-class research program since her appointment in September 2022. With a foundation in pharmaceutical sciences, she earned her Doctorate in Pharmacy before advancing her expertise through engineering studies at the University of Lyon under the mentorship of Professor Hatem Fessi. Her academic trajectory progressed from Maître de conférence in galenic pharmacy to her current prestigious professorship, reflecting her significant contributions to the science of therapeutic formulation and nanomedicine development.
Professor Bouchemal's groundbreaking research has revolutionized the field through the development of anisotropic nanoparticles derived from polysaccharides and cyclodextrins, creating innovative platforms for targeted drug delivery with enhanced therapeutic efficacy. Her highly influential work on hyaluronic acid particles has yielded patentable formulations that address mucosal inflammation, as demonstrated in her seminal publication in the Journal of Controlled Release which established new paradigms for geometrically optimized nanomedicines. With scientific contributions cited by over 850 publications, her research with collaborator Christine Vauthier has substantially advanced the understanding of how nanoparticle architecture influences biodistribution and therapeutic outcomes. Her methodological innovations have provided the pharmaceutical industry with new approaches to overcome traditional limitations in drug solubility, stability, and site-specific delivery.
As Principal Investigator at the Institut de Recherche de Chimie Paris, Professor Bouchemal has cultivated a dynamic research environment that bridges fundamental polymer chemistry with translational medical applications while training the next generation of pharmaceutical scientists. Her leadership in the French research community has shaped national priorities in nanomedicine development and pharmaceutical formulation science through strategic collaborations with both academic and industry partners. Currently directing multiple cutting-edge research projects, she continues to pioneer new approaches to nanotherapeutic design that address unmet clinical needs in inflammatory diseases. Professor Bouchemal remains at the forefront of developing intelligent drug delivery systems that optimize therapeutic precision while minimizing side effects, positioning her work to significantly impact future pharmaceutical development and patient care worldwide.
